Gary has worked in the healthcare and medical device industry since 1981, including thirteen years as a senior executive in three private equity backed ventures. Gary began his career in healthcare with United States Surgical Corporation where he spent 22 years in roles of increasing responsibilities including Vice President of Sales Operations and Distribution Sales for Tyco Healthcare following the acquisition of USS by Kendall. He next joined UTI Corporation as Executive Vice President of Sales and Marketing where he led the Sales and Marketing strategy though the acquisition and integration of MedSource Technologies, the re-branding of the combined organization as Accellent, and through its acquisition by Kohlberg, Kravis, and Roberts in 2005. Gary then joined THP’s portfolio company Interface Catheter Solutions as President, CEO. He led the strategic growth into contract manufacturing resulting in its acquisition by NDC/Confluent Medical in 2015. Most recently, Gary was President of Trelyst, a subsidiary of NuSil Technology LLC focused on developing silicone based combination drug-delivery devices for implantation to address the growing issue of medication adherence. He led the organization through its merger with Avantor. Gary has represented THP on the boards of Aquaro, Argonaut Manufacturing Services, InvisAlert and Medpricer. Gary holds a Bachelor of Science in Marketing from Millikin University.
Gary D. Curtis